S8875
重炭酸ナトリウム
ReagentPlus®, ≥99.5%, powder
別名:
炭酸水素ナトリウム
ログインで組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
この商品について
化学式:
NaHCO3
CAS番号:
分子量:
84.01
UNSPSC Code:
12352302
NACRES:
NA.21
PubChem Substance ID:
EC Number:
205-633-8
Beilstein/REAXYS Number:
4153970
MDL number:
eCl@ss:
38020213
Assay:
≥99.5%
Form:
powder
agency
suitable for EPA 300
Quality Level
product line
ReagentPlus®
assay
≥99.5%
form
powder
pKa (25 °C)
(1) 6.37, (2) 10.25 (carbonic acid)
density
2.16 g/mL at 25 °C (lit.)
SMILES string
[Na+].OC([O-])=O
InChI
1S/CH2O3.Na/c2-1(3)4;/h(H2,2,3,4);/q;+1/p-1
InChI key
UIIMBOGNXHQVGW-UHFFFAOYSA-M
General description
炭酸水素ナトリウムは一般に重曹として知られています。二酸化炭素の供給源となり、さまざまなナトリウム塩の調製に使用されます。重要なpH調整剤でもあります。
Application
炭酸水素ナトリウムは以下で触媒として使用できます。
- 共触媒としての硫酸ナトリウムの存在下で、対応するアルデヒドと塩酸ヒドロキシルアミンからニトリルを合成。
- 置換2-ホルミルフェニル2-ブロモ酢酸の分子内ウィッティヒ反応によるクマリン誘導体の調製
- 無水酢酸との反応による第一級アルコールおよびフェノールのアセチル化。
Legal Information
ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
Still not finding the right product?
Explore all of our products under 重炭酸ナトリウム
flash_point_f
Not applicable
flash_point_c
Not applicable
保管分類
11 - Combustible Solids
プロトコル
This procedure may be used for the determination of Amyloglucosidase activity using starch as the substrate.
This procedure may be used for all Ficin products.
関連コンテンツ
This page is intended to make it easier to find the consumables you need based on the analytical method you’re using. Methods included on this page come from the EPA, Standard Methods and ASTM.
Shay P McGuinness et al.
Critical care medicine, 41(7), 1599-1607 (2013-05-21)
Cardiac surgery-associated acute kidney injury occurs in up to 50% of patients and is associated with increased mortality and morbidity. This study aimed to discover if perioperative urinary alkalinization with sodium bicarbonate infusion reduces the prevalence of cardiac surgery-associated acute
Somjot S Brar et al.
Clinical journal of the American Society of Nephrology : CJASN, 4(10), 1584-1592 (2009-08-29)
Infusion of sodium bicarbonate has been suggested as a preventative strategy but reports are conflicting on its efficacy. The aim of this study was to assess the effectiveness of hydration with sodium bicarbonate for the prevention of contrast-induced acute kidney
Sophia Zoungas et al.
Annals of internal medicine, 151(9), 631-638 (2009-11-04)
Intravenous sodium bicarbonate has been proposed to reduce the risk for contrast-induced nephropathy (CIN). To determine the effect of sodium bicarbonate on the risk for CIN. MEDLINE, PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials from 1950 to